> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on IND Reporting Requirements Extension
- URL: https://www.fdaweb.com/comments-sought-on-ind-reporting-requirements-extension-2/
- Published: 2016-10-26T12:00:00.000Z
- Updated: 2026-09-14T21:42:50.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137180

*Federal Register* Notice: FDA is asking for comments on a submission to OMB seeking to extend an information collection related to “Format and Content Requirements for OTC Drug Product Labeling — 21 CFR Part 201.” The regulations in Part 201 require OTC drug product labeling to include uniform headings and subheadings, presented in a standardized order, with minimum standards for type size and other graphical features. To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-10-26/pdf/2016-25854.pdf?ref=fdaweb.com).